Dear Reader,

Welcome to the final issue of Drugs—Real World Outcomes for 2023.

We would like to reflect on this year’s achievements and to thank all those who have contributed their valuable time and effort to the journal over the past 12 months.

We would like to start by thanking the authors of the articles published in Drugs—Real World Outcomes over the course of 2023. The skill and dedication of these experts is critical to the continued success of the journal.

We are excited to share the news that Drugs—Real World Outcomes received its first Impact Factor of 2.0 in the Journal Citation Reports™ (Clarivate) in June 2023. The high quality of articles published in Drugs—Real World Outcomes has also been reflected in the most recent CiteScore of 2.9.

The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would therefore like to thank the following individuals who acted as reviewers for Drugs—Real World Outcomes in the last 12 months:

Emma Aarnio, Finland

Nafees Ahmad, Pakistan

Eman A. Alghamdi, Saudi Arabia

Nebyu D. Amaha, Ethiopia

Mary S. Anthony, USA

Michael Auer, Austria

Nobutaka Ayani, Japan

Maria Antonietta Barbieri, Italy

Jeffrey Berinstein, USA

Cesare Berra, Italy

Achenef M. Beyene, Ethiopia

Kim Blond, Denmark

Richard Bockman, USA

Ivana Bojanić, Norway

Vittorio Bolcato, Italy

Sander Borgsteede, the Netherlands

Stefan Braune, Germany

Rachel Britt, USA

Marta J. Brooks, USA

Shawn Bugden, Canada

Anthony Buisson, France

Héctor Cabello-Rangel, Mexico

Andrea Camerini, Italy

Sankha S. Chakrabarti, India

Javier Cid Ruzafa, Spain

Antonio Clavenna, Italy

Ineke Crijns, the Netherlands

Heather Danysh, USA

Catherine G. Derington, USA

Christopher J. Destache, USA

Mark A. Dusheiko, Switzerland

Trevor Ellison, USA

Kenneth Ernest-Suarez, Canada

Tesfahun Eshetie, Australia

Augusto Ferraris, Argentina

Francesca Fiorentino, Italy

Leorah Freeman, USA

Jun Fujinaga, Japan

Masaki Fujita, Japan

Vittorio Gebbia, Italy

Evangelos Giamarellos-Bourboulis, Greece

Sergey Golubev, Belarus

Gisela Gonzalez, Argentina

Swarnali Goswami, USA

Verena Gotta, Switzerland

Jing Gu, USA

Deniz Can Guven, Turkey

Mario Habek, Croatia

Mohammad H. Hashempur, Islamic Republic of Iran

Delfina F. Hlashwayo, Mozambique

Kazuya Hosokawa, Japan

John E. Hughes, Ireland

Kenya Ie, Japan

Ryo Iketani, Japan

Sushmitha Inguva, USA

Dolores Isla, Spain

Tianze Jiao, USA

Ted Johnson, USA

Michalis Katsoulis, UK

Hideki Katsura, Japan

Karel Kostev, Germany

Ashwath Kumar, USA

Katrin Kurvits, Estonia

Joëlle Lanser, the Netherlands

Leire Leache, Spain

Willem Lems, the Netherlands

Anne-Marie Leroi, France

Tingting Li, USA

Weijia Li, USA

Xiaotong Li, USA

David Liew, Australia

Junjing Lin, USA

Andrea Lindsey, USA

Hideki Maeda, Japan

Dederieke Maes-Festen, the Netherlands

Seyed H. Mahmoudpour, Germany

Mortimier M. Mamelak, Canada

Andrea Margulis, Spain

Clara Marquina, Australia

Lubov Matchekhina, The Russian Federation

Rano Matta, Canada

Geert Mayer, Germany

Nobuaki Michihata, Japan

Motoyasu Miyazaki, Japan

Marcello Moccia, Italy

Cliff Molife, USA

Yola Moride, USA

Robert P. Morris, USA

Tinashe Mudzviti, Zimbabwe

Milena Murray, USA

Junko Nagai, Japan

Sujita Narayan, Australia

Mamoru Narukawa, Japan

Takatoshi Nawa, Japan

Ole Haagen Nielsen, Denmark

Rajeshwar Nitiyanandan, USA

Jenny M. Norlin, Sweden

Tetsuya Okano, Japan

Shunsuke Ono, Japan

Khalid Orayj, Saudi Arabia

Kampadilemba Ouoba, Burkina Faso

Thanh Phuong Pham Nguyen, USA

Sherman Picardo, Canada

Maurizio Pompili, Italy

Sergio I. Prada, Colombia

Mahbubur Rashid, Australia

Nazia Rashid, USA

Jayachandran Ravichandran, USA

Itamar Raz, Israel

Anthony T. Reder, USA

Sanika Rege, USA

Joseph Reilly, USA

Jose Rocha, Portugal

Albert Roger, Spain

Yossi Rosman, Israel

Barbara Ruaro, Italy

Cristina Ruas, Brazil

Masataka Sawaki, Japan

Rajani Sharma, India

Lunda Shen, USA

Tadashi Shimizu, Japan

Tahreem G. Siddiqui, Norway

Eva Sönnerstam, Sweden

Ross A. Soo, Singapore

Patrick Souverein, the Netherlands

Marios Spanakis, Greece

Dorothea Strobach, Germany

Matej Stuhec, Slovenia

Thanarat Suansanae, Thailand

Vinita Subramanya, USA

Yasuaki Tagashira, Japan

Masahiro Takeshima, Japan

Masato Takeuchi, Japan

Sandra Thiel, Germany

Glenn S. Tillotson, USA

Kanae Togo, Japan

Francesco Tovoli, Italy

Dat T. Tran, Canada

Masami Tsuchiya, Japan

Kiyotaka Uchiyama, Japan

Maria Valdovinos, USA

Wout van den Broek, the Netherlands

Daisy Volmer, Estonia

Jingjun Wang, USA

Tzu-Chueh Wang, Taiwan, Republic of China

Sawaeng Watcharathanakij, Thailand

Maureen B. G. Wissing, the Netherlands

Saranrat Wittayanukorn, USA

Zongqi Xia, USA

Chen Yang, China

Yizhou Ye, USA

Changhoon Yoo, Republic of Korea

Pedro Zapater, Spain

Dongmu Zhang, USA

Huanxue Zhou, USA

We gratefully acknowledge all the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:

Dr G. Caleb Alexander, MD. Johns Hopkins University, Baltimore, MD, USA.

Associate Professor W. Alsabbagh, PhD. University of Waterloo, Kitchener, ON, Canada

Dr Ariel Beresniak, MD MPH PhD. Data Mining International, Geneva, Switzerland.

Dr Juliana M. Bottomley, PhD. Amygdala Ltd, Letchworth Garden City, England.

Dr Juanita Breen, PhD, MSc, BPharm. University of Tasmania, Hobart, TAS, Australia.

Dr Maria Stella T. Giron, MD, PhD. University of the Philippines Manila, Manila, Philippines.

Dr Brian Godman, PhD. Karolinska Institutet, Stockholm, Sweden.

Dr David Goldsmith, MD. Goldsmith Pharmacovigilance and Systems, New York, NY, USA.

Professor Maria Gustafsson, PhD. University of Umea, Umea, Sweden.

Dr Klejda Harasani, PhD. University of Medicine, Tirana, Albania.

Dr Emily Karanges, PhD. University of Melbourne and Orygen, Parkville, VIC, Australia.

Dr Sudeep Karve, PhD. AbbVie, Chicago, IL, USA.

Dr Ronald Kiguba, PhD. Makerere University, Kampala, Uganda.

Dr Shunsuke Kiuchi, MD, PhD. Toho University Graduate School of Medicine, Tokyo, Japan.

Dr Chris M. Kozma, PhD. CK Consulting Associates, St. Helena Island, SC, USA.

Dr Tamar Lasky, PhD. U.S. Food and Drug Administration, Silver Spring, MD, USA.

Dr Giancarlo Lucchetti, MD, PhD. Federal University of Juiz de Fora, Juiz de Fora, Brazil.

Professor Jorge E. Machado-Alba, MD, PhD. Universidad Tecnologica de Pereira, Pereira, Colombia.

Adjunct Professor Diego Macías Saint-Gerons, PhD. University of Valencia/INCLIVA Health Research Institute and CIBERSAM, Valencia, Spain.

Professor Arduino A.Mangoni, MD, PhD, FRCP, FRACP. Flinders University, Adelaide, SA, Australia.

Dr Suzana Mimica-Matanovic, MD, PhD. University Hospital Osijek, Osijek, Croatia.

Professor Mihoko Okada, PhD. Institute of Health Data Infrastructure for All, Tokyo, Japan.

Dr Tasuku Okui, PhD. Kyushu University Hospital, Fukuoka, Japan.

Dr Alexandra C. Pacurariu, PhD. IQVIA, London, United Kingdom.

Dr Vidhya Parameswaran, MPH. AstraZeneca, Cambridge, MA, USA

Dr Priyakumari Ganesh Parmar, PhD. Auckland University of Technology, Auckland, New Zealand.

Dr Ana V. Pejčić, PhD, MPharm. University of Kragujevac, Kragujevac, Serbia.

Professor Barbara Rinaldi, PhD. University of Capania Luigi Vanvitelli, Naples, Italy.

Dr Melissa H. Roberts, PhD. University of New Mexico, Albuquerque, NM, USA.

Dr Mulugeta Russom, MSc. Eritrea National Medicines and Food Administration, Asmara, Eritrea.

Professor Tsuyoshi Shiga, MD. The Jikei University School of Medicine, Tokyo, Japan.

Dr Janet K. Sluggett, BPharm(Hons), PhD. Monash University, Parkville, VIC, Australia.

Dr Keith A. Swanson, PharmD. University of Oklahoma, Oklahoma City, OK, USA.

Dr Balamurugan Tangiisuran, PhD, MPharm, BPharm. Universiti Sains Malaysia, Penang, Malaysia.

Dr Florence van Hunsel, PharmD. The Netherlands PharmacovigilanceCentre Lareb, Brabant, The Netherlands.

Dr John E. Ware Jr., PhD. John Ware Research Group Incorporated,Watertown, MA, USA.

Dr Quan Zou, PhD. Medstar Health Research Institute, Washington, DC, USA.

Through the hard work of our authors and reviewers, we continue to see great gains in article usage. The most popular recent articles to date, in terms of downloads from SpringerLink, were:

Wakabayashi R, Hirano T, Laurent T, et al. Impact of “time zero” of Follow-Up Settings in a Comparative Effectiveness Study Using Real-World Data with a Non-user Comparator: Comparison of Six Different Settings. Drugs—Real World Outcomes 2022; 10: 107–117. https://link.springer.com/article/10.1007/s40801-022-00343-1.

Macías Saint-Gerons D, Ibarz MT, Castro JL, et al. Myopericarditis Associated with the Novavax COVID-19 Vaccine (NVX-CoV2373): A Retrospective Analysis of Individual Case Safety Reports from VigiBase. Drugs—Real World Outcomes 2023; 10: 263–270. https://link.springer.com/article/10.1007/s40801-023-00355-5.

Furuse J, Izumi N, Motomura K, et al. Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan. Drugs—Real World Outcomes 2023; 10: 195–205. https://link.springer.com/article/10.1007/s40801-022-00348-w.

Gudeman J and Burroughs D. Evidence of Accidental Dosing Errors with Immediate-Release Sodium Oxybate: Data from the US Food and Drug Administration Adverse Event Reporting System. Drugs—Real World Outcomes 2023; 10: 225–234. https://link.springer.com/article/10.1007/s40801-023-00351-9.

Lee P, Kistler KD, Douyon L, et al. Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma. Drugs—Real World Outcomes 2023; 10: 11–22. https://link.springer.com/article/10.1007/s40801-022-00332-4

We hope that you have found the articles published throughout 2023 to be both interesting and informative. We have appreciated the high quality of content contributed to the journal and we look forward to keeping you up to date with topical issues in in 2024.

With best wishes,

Dene Peters

Editor-in-Chief, Drugs—Real World Outcomes

Sophie Stevenson

Associate Editor, Drugs—Real World Outcomes